BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33470769)

  • 1. Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study.
    Zeydan B; Lowe VJ; Tosakulwong N; Lesnick TG; Senjem ML; Jack CR; Fields JA; James TT; Gleason CE; Dowling NM; Miller VM; Kantarci K
    Neuroreport; 2021 Mar; 32(4):326-331. PubMed ID: 33470769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
    Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
    J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Lowe VJ; Fields JA; Gunter JL; Senjem ML; Settell ML; Gleason CE; Shuster LT; Bailey KR; Dowling NM; Asthana S; Jack CR; Rocca WA; Miller VM
    Neurology; 2018 Apr; 90(16):e1404-e1412. PubMed ID: 29661902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma orexin A levels in recently menopausal women during and 3 years following use of hormone therapy.
    Cintron D; Beckman JP; Bailey KR; Lahr BD; Jayachandran M; Miller VM
    Maturitas; 2017 May; 99():59-65. PubMed ID: 28364870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
    Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
    JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from KEEPS: the Kronos Early Estrogen Prevention Study.
    Miller VM; Taylor HS; Naftolin F; Manson JE; Gleason CE; Brinton EA; Kling JM; Cedars MI; Dowling NM; Kantarci K; Harman SM
    Climacteric; 2021 Apr; 24(2):139-145. PubMed ID: 32880220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
    Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
    Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the effects of oral conjugated equine estrogen and transdermal estradiol-17 beta combined with an oral progestin on quality of life in postmenopausal women.
    Hilditch JR; Lewis J; Ross AH; Peter A; van Maris B; Franssen E; Charles J; Norton P; Dunn EV
    Maturitas; 1996 Jul; 24(3):177-84. PubMed ID: 8844631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
    Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
    PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Hormone Therapy on Heart Fat and Coronary Artery Calcification Progression: Secondary Analysis From the KEEPS Trial.
    El Khoudary SR; Zhao Q; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman SM; Cedars MI; Hopkins PN; Kearns AE; Miller VM; Taylor HS; Budoff MJ
    J Am Heart Assoc; 2019 Aug; 8(15):e012763. PubMed ID: 31652073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
    El Khoudary SR; Venugopal V; Manson JE; Brooks MM; Santoro N; Black DM; Harman M; Naftolin F; Hodis HN; Brinton EA; Miller VM; Taylor HS; Budoff MJ
    Menopause; 2020 Mar; 27(3):255-262. PubMed ID: 32015261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Menopausal hormone therapy, blood thrombogenicity, and development of white matter hyperintensities in women of the Kronos Early Estrogen Prevention Study.
    Jayachandran M; Lahr BD; Bailey KR; Miller VM; Kantarci K
    Menopause; 2020 Mar; 27(3):305-310. PubMed ID: 31934946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Markers of Neurovascular Unit Integrity and Amyloid-β in the Brains of Menopausal Women.
    Jayachandran M; Miller VM; Lahr BD; Bailey KR; Lowe VJ; Fields JA; Mielke MM; Kantarci K
    J Alzheimers Dis; 2021; 80(1):397-405. PubMed ID: 33554914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study.
    Miller VM; Hodis HN; Lahr BD; Bailey KR; Jayachandran M
    Menopause; 2019 Jan; 26(1):24-31. PubMed ID: 30020254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study.
    Santoro N; Allshouse A; Neal-Perry G; Pal L; Lobo RA; Naftolin F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Dowling NM; Dunn M; Gleason CE; Hodis HN; Isaac B; Magnani M; Manson JE; Miller VM; Taylor HS; Wharton W; Wolff E; Zepeda V; Harman SM
    Menopause; 2017 Mar; 24(3):238-246. PubMed ID: 27779568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hormone therapy on brain structure: A randomized controlled trial.
    Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Gunter JL; Gleason CE; Wharton W; Dowling NM; Vemuri P; Senjem ML; Shuster LT; Bailey KR; Rocca WA; Jack CR; Asthana S; Miller VM
    Neurology; 2016 Aug; 87(9):887-96. PubMed ID: 27473135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of hormone therapy on serotonin, vascular function and mood in the KEEPS.
    Raz L; Hunter LV; Dowling NM; Wharton W; Gleason CE; Jayachandran M; Anderson L; Asthana S; Miller VM
    Climacteric; 2016; 19(1):49-59. PubMed ID: 26652904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens.
    Wroolie TE; Kenna HA; Williams KE; Powers BN; Holcomb M; Khaylis A; Rasgon NL
    Am J Geriatr Psychiatry; 2011 Sep; 19(9):792-802. PubMed ID: 21873835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women.
    Farr JN; Khosla S; Miyabara Y; Miller VM; Kearns AE
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E249-57. PubMed ID: 23322818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.